- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02234167
The Swedish Prison Program is an Intervention Prevention Program Targeting Injecting Drug Users Risk Behaviours and Infectious Diseases (SHP)
Svenska Häktesprogrammet, Prevention, Risk Behaviour and Infectious Diseases Among IDU.
The purpose of the Swedish Prison Program which started back in 1987 and up until 2009 was called "The Social Medicine Remand Prison Project" is to target injecting drug users (IDU) with primary and secondary health interventions with regards to injecting and sexual risk behaviours and infectious diseases such as hepatitis C and B, HIV and sexually transmitted infections (STI).
The overall aim is to assess the effect of different prevention efforts on HIV/HCV risk behaviour and disease outcome among IDUs over time.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden
- SHP
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Defined as an injecting drug user, in the prison and probation service and agree to anonymously participate
Exclusion Criteria:
- Being defined as a non-drug user, non-injecting drug user
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Risk behaviour and infectious diseases
.(among IDU)
|
through counselling, testing vaccination
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with injection risk behaviour
Time Frame: 2002-2012
|
Have you received already used injection equipment from someone last 12 months Have you lent (away) already used injection equipment to someone last 12 months Have you shared solution and/or filter with someone last 12 months Number of people shared needles with last month Number of injections last month Number of Hepatitis C positive Number of HIV positive Number of Hepatitis B positive Number of respondenst positive for sexually transmitted infections
|
2002-2012
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with infectious diseases
Time Frame: 2002-2012
|
HIV, HCV, HBV and STI
|
2002-2012
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Swedish Prison Program
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Risk behaviour and infectious diseases
-
University Hospital, Clermont-FerrandRecruiting
-
Roswell Park Cancer InstituteCompletedMalignant Female Reproductive System NeoplasmUnited States
-
Central Hospital, Nancy, FranceEnrolling by invitationEncephalitis | Meningitis | Tick Bites | Viral EncephalitisFrance
-
University Hospital, EssenCompletedCardiovascular Diseases | Cardiovascular Risk Factor | SARSGermany
-
University of GlasgowGlaxoSmithKlineWithdrawnDiabetes Mellitus, Type 2 | Angina PectorisUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisRecruitingChronic Disease | Somatic DisordersFrance
-
UMC UtrechtRijnstate HospitalCompletedCardiovascular DiseasesNetherlands
-
West China HospitalActive, not recruitingCarcinoma, Renal Cell | Immunotherapy | Fumarate Hydratase DeficiencyChina
-
Capital Medical UniversityTerminated
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedTobacco Product Beliefs and UseUnited States